Description
The Department of Veteran Affairs, Network Contracting Office (NCO) 16, intends to issue a sole-source contract to Thermofisher Scientific for the provision of clinical products, including reagents, kits, and consumables, for in vitro diagnostic medical devices. The contract is intended to aid in the management of kidney and liver allograft patients receiving tacrolimus therapy at the Southeast Louisiana Veterans Health Care Service. The period of performance shall be for November 1, 2025, to September 30, 2026, and four option years, each 12 months in length.
• The contract is for a firm-fixed-price service contract.
• Interested parties may express their interest by providing a capabilities statement not later than October 27, 2025, at 3:00 PM CST.
• The capabilities statement must provide clear and unambiguous evidence to substantiate the capability of the party to provide the required services.
• Responding as an interested party under the www.beta.sam.gov website does not constitute convincing evidence of capabilities.